Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 AUD | +6.12% | -11.86% | -8.77% |
05-28 | Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD | CI |
05-28 | Opthea Completes Enrollments in COAST, ShORe Trials | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
OPTHEA LIMITED | Other Biotechnology & Medical Research | +6.12% | -11.86% | -8.77% | -14.05% | -18.11% | 216M |
Technical Rankings Surperformance
- Stock Market
- Equities
- OPT Stock
- Charts Opthea Limited
- Comparison Chart